Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: Preoperative and real-time intraoperative dosimetry planning-Reference-Cited by-同舟云学术

Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: Preoperative and real-time intraoperative dosimetry planning

Published:2012-07 Issue:4 Volume:30 Page:379-385
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Matzkin Haim,Chen Juza,Stenger Amira,Agai Rubi,Mabjeesh Nicola J.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference33 articles.

1. Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1,050 patients with clinical T1–T2 prostate cancer;Guedea;Radiother Oncol,2006

2. Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation;Zelefsky;Int J Radiat Oncol Biol Phys,2007

3. 15-Year biochemical relapse free survival in clinical Stage T1–T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2007

4. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications;Blasko;Scand J Urol Nephrol Suppl,1991

5. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma;Ragde;Cancer,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between preoperative and real-time intraoperative planning 125I permanent prostate brachytherapy: long-term clinical biochemical outcome;Radiation Oncology;2013-12

2. Comparison of Preplanning and Intraoperative Planning for I-125 Prostate Brachytherapy;Japanese Journal of Clinical Oncology;2013-01-11

3. Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with 125iodine brachytherapy;BJU International;2011-11-24